John Cox

John Cox

Directeur Général chez DYNE THERAPEUTICS, INC.

Fortune : 147 094 $ au 31/07/2023

61 ans
Health Technology
Consumer Services
Finance

Provenance du réseau au premier degré de John Cox

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 202
44
Subsidiary Pharmaceuticals: Major 44
Public Company Biotechnology 24
Public Company Pharmaceuticals: Major 21
Public Company Biotechnology 20
Subsidiary Biotechnology 15
10
Holding Company Miscellaneous Commercial Services 10
7
Holding Company Pharmaceuticals: Major 7
6
Subsidiary Pharmaceuticals: Major 6
6
Subsidiary Biotechnology 6

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à John Cox via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Massachusetts Institute of Technology College/University

Michael Gilman

William Rastetter

Phillip Sharp

Alexander Denner

Walter C. Herlihy

Susan Hockfield

Douglas A. Lauffenburger

Richard Mulligan

Stephen Berenson

Martha Rook

Michael Hencke

Undergraduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Major

Stephen Sherwin

Caroline Dorsa

Eric Rowinsky

Stelios Papadopoulos

Brian Posner

Alexander Denner

Richard Mulligan

Michel Vounatsos

Director/Board Member

Director/Board Member

Director/Board Member

Chairman

Director/Board Member

Director/Board Member

Director/Board Member

Chief Executive Officer

PFIZER, INC. Pharmaceuticals: Major

Susan Hockfield

Torben Nissen

Jose-Carlos Gutiérrez-Ramos

Geno Germano

Eric Shaff

Trevor Anthony Mill

John Davis

Director/Board Member

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Bentley University College/University

Gina Consylman

Glenn Muir

David Lubner

Lynne Sullivan

Vikas Gupta

John Najim

Graduate Degree

Graduate Degree

Graduate Degree

Graduate Degree

Graduate Degree

Masters Business Admin

MERCK & CO., INC. Pharmaceuticals: Major

Caroline Dorsa

Nicolas Barthelemy

Fred Hassan

Bart Henderson

Michel Vounatsos

Diantha Duvall

Corporate Officer/Principal

Corporate Officer/Principal

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

Yale University College/University

Stephen Sherwin

Stephen Oesterle

Alexander Denner

Susan Hockfield

Eric S. Hoffman

Jason Rhodes

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Major

Eric Rowinsky

William Rastetter

William Young

James Mullen

Stelios Papadopoulos

Michel Vounatsos

Director/Board Member

Chairman

Director/Board Member

Chief Executive Officer

Director/Board Member

Chief Executive Officer

THERMO FISHER SCIENTIFIC Medical Specialties

Jon Snodgres

James Mullen

Amy Reilly

Michael Dambach

James Bylund

Director of Finance/CFO

Director/Board Member

Public Communications Contact

Corporate Officer/Principal

Corporate Officer/Principal

College/University

William Kelly

David Lubner

Andrea DiFabio

Diantha Duvall

Rohin Mhatre

Graduate Degree

Undergraduate Degree

Graduate Degree

Graduate Degree

Doctorate Degree

Harvard Medical School College/University

Stephen Sherwin

Stephen Oesterle

Jose-Carlos Gutiérrez-Ramos

Richard Mulligan

Wildon Farwell

Doctorate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Alexander Denner

Richard Mulligan

Carlo Incerti

Eric Shaff

Josias Fantato De Pontes

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Comptroller/Controller/Auditor

University of Massachusetts College/University

Glenn Muir

Christine Gebski

Rick Scalzo

Debra Feldman

Nicole Murphy

Undergraduate Degree

Graduate Degree

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Investment Managers

Jason Rhodes

Joshua Brumm

Samantha Truex

Catherine Stehman-Breen

Private Equity Investor

Consultant / Advisor

Consultant / Advisor

Consultant / Advisor

POIT BIOP Pharmaceuticals: Major

David Lubner

Philip Johnson

Michael Thompson

Chris Anderson

Director/Board Member

President

Director/Board Member

Director/Board Member

AMGEN INC. Pharmaceuticals: Major

Fred Hassan

Bart Henderson

Catherine Stehman-Breen

Thomas-Christian Mix

Director/Board Member

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Boston University College/University

Jonathan Lieber

Andrea DiFabio

Michael Dambach

Debra Feldman

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Graduate Degree

Harvard Business School College/University

Fred Hassan

Glenn Muir

Glenn M. Reicin

Michael Hencke

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Miscellaneous Commercial Services

Stephen Sherwin

Robert Ruffolo

James Mullen

Geno Germano

Chairman

Director/Board Member

Chairman

Director/Board Member

Biotechnology

Stephen Sherwin

William Rastetter

William Young

V. Lawlis

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

The University of Chicago College/University

Robert Essner

Catherine Stehman-Breen

Philip Ashton-Rickardt

Graduate Degree

Doctorate Degree

Corporate Officer/Principal

University of California, Berkeley College/University

Nicolas Barthelemy

Michael Gilman

Qing Sarah Yuan

Graduate Degree

Doctorate Degree

Undergraduate Degree

Rensselaer Polytechnic Institute College/University

James Mullen

Ralf Kuriyel

Nicole Murphy

Undergraduate Degree

Graduate Degree

Masters Business Admin

Investment Managers

Douglas Cole

Torben Nissen

Stephen Berenson

Private Equity Investor

Private Equity Investor

Private Equity Investor

Pharmaceuticals: Major

Michael Dambach

Lynne Sullivan

Mahalakshmi Radhakrishnan

Director/Board Member

Director/Board Member

Corporate Officer/Principal

DICE THER Biotechnology

Philip Johnson

Michael Thompson

Chris Anderson

President

Director/Board Member

Corporate Secretary

University of Pennsylvania College/University

Eric Shaff

Jonathan McNeill

Daniel Wilson

Undergraduate Degree

Graduate Degree

Graduate Degree

REGULUS THERAPEUTICS INC. Pharmaceuticals: Major

William Rastetter

Stelios Papadopoulos

B. Parshall

Director/Board Member

Chairman

Director/Board Member

KALEIDO BIOSCIENCES, INC. Pharmaceuticals: Major

Joshua Brumm

Amy Reilly

Rick Scalzo

Director of Finance/CFO

Investor Relations Contact

Comptroller/Controller/Auditor

Biotechnology

Eric Rowinsky

Alexander Denner

Richard Mulligan

Chief Tech/Sci/R&D Officer

Director/Board Member

Director/Board Member

BG MEDICINE, INC. Medical Specialties

Stelios Papadopoulos

Brian Posner

Timothy Harris

Director/Board Member

Director/Board Member

Director/Board Member

IRONWOOD PHARMACEUTICALS, INC. Pharmaceuticals: Major

Gina Consylman

Alexander Denner

Bart Henderson

Director of Finance/CFO

Director/Board Member

Corporate Officer/Principal

University of Illinois College/University

Phillip Sharp

Douglas A. Lauffenburger

Philip Johnson

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

FOGHORN THERAPEUTICS INC. Biotechnology

Douglas Cole

B. Parshall

Carlos Costa

Founder

Director/Board Member

Human Resources Officer

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

William Young

Douglas Cole

Bart Henderson

Director/Board Member

Corporate Officer/Principal

Sales & Marketing

Harvard College College/University

Glenn L. Cooper

Stephen Oesterle

B. Parshall

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

SANA BIOTECHNOLOGY, INC. Biotechnology

Douglas Cole

Steven Harr

Richard Mulligan

Director/Board Member

Founder

Chief Tech/Sci/R&D Officer

VERASTEM, INC. Biotechnology

Stephen Sherwin

Eric Rowinsky

Gina Consylman

Director/Board Member

Director/Board Member

Director/Board Member

EDITAS MEDICINE, INC. Biotechnology

James Mullen

Douglas Cole

Jonathan McNeill

Chief Executive Officer

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Phillip Sharp

Susan Hockfield

Richard Mulligan

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Biotechnology

Robert Ruffolo

Robert Essner

Geno Germano

Director/Board Member

Chairman

Chief Executive Officer

GSK PLC Pharmaceuticals: Major

Robert Ruffolo

Jose-Carlos Gutiérrez-Ramos

Corporate Officer/Principal

Corporate Officer/Principal

908 DEVICES INC. Medical Specialties

Nicolas Barthelemy

Tony Hunt

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Robert Ruffolo

Geno Germano

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Investment Banks/Brokers

Stelios Papadopoulos

Jonathan Lieber

Director/Board Member

Corporate Officer/Principal

ASCENDIS PHARMA A/S Pharmaceuticals: Major

Torben Nissen

Dirk Kersten

Chief Operating Officer

Director/Board Member

College/University

William Rastetter

Anne Walker

Doctorate Degree

Undergraduate Degree

Investment Managers

Jason Rhodes

Catherine Stehman-Breen

Private Equity Investor

Consultant / Advisor

The Hebrew University of Jerusalem College/University

Uriel Halavee

Shmuel Cabilly

Doctorate Degree

Doctorate Degree

BIOMX INC. Biotechnology

Michael Dambach

Lynne Sullivan

Director/Board Member

Director/Board Member

Statistiques

Internationale

Etats-Unis 45
Israël 4
Allemagne 2
Royaume-Uni 2
Danemark 2

Sectorielle

Health Technology 28
Consumer Services 16
Finance 7
Commercial Services 3

Opérationnelle

Director/Board Member 569
Corporate Officer/Principal 228
Independent Dir/Board Member 187
Chairman 97
Undergraduate Degree 83
  1. Bourse
  2. Insiders
  3. John Cox
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT